Characteristics of Immunocytes and Cytokines in Patients with Bloodstream Infections Caused by Carbapenem-Resistant Klebsiella pneumoniae in China
Wenhui Guo,Xiang Lian,Hong Li,Lushun Jiang,Yingsha Chen,Ping Shen,Wei Yu
DOI: https://doi.org/10.2147/idr.s431207
2024-02-22
Infection and Drug Resistance
Abstract:Wenhui Guo, 1, &ast Xiang Lian, 2, &ast Hong Li, 2 Lushun Jiang, 1 Yingsha Chen, 3 Ping Shen, 1 Wei Yu 1 1 State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, People's Republic of China; 2 Department of Infectious Diseases, The Affiliated Xiangshan Hospital of Wenzhou Medical University; Xiangshan First People's Hospital Medical and Health Group; Ningbo Fourth Hospital, Ningbo, People's Republic of China; 3 Department of Infectious Diseases, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, People's Republic of China &astThese authors contributed equally to this work Correspondence: Ping Shen; Wei Yu, State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, People's Republic of China, Tel/Fax +86 571 87236421, Email ; Objective: To evaluate the characteristics of immunocytes and cytokines associated with bloodstream infections (BSIs) caused by carbapenem-resistant Klebsiella pneumoniae (CRKP). Methods: Patients with BSIs K. pneumoniae (BSIs-Kpn) were enrolled in our hospital between 2015 and 2022. Whole blood and serum samples were collected on the first day after diagnosis. Immunocytes and cytokines profiles were assessed using multicolor flow cytometry and multiplex immunoassays, respectively. The test cytokines included interferon-gamma (IFN-γ), tumor necrosis factor-alpha (TNF-α), interleukin (IL)-2, IL-4, IL-6, IL-10, and IL-17A. Results: A total of 313 patients had BSIs-Kpn, including 145 with CRKP, 43 with extended-spectrum β-lactamases (ESBL) producing Kpn (ESBL-Kpn) and 125 with non-CRKP or non-ESBL-Kpn (susceptible Kpn, S-Kpn). Absolute number of leukomonocyte (CD45+) in CRKP, ESBL-Kpn and S-Kpn were 280.0 (138.0– 523.0) cells/μL, 354.5 (150.3– 737.3) cells/μL, and 637.0 (245.0– 996.5) cells/μL, respectively. Compared with S-Kpn group, the absolute numbers of leukomonocyte (including T lymphocytes, B lymphocytes and natural killer cells) in patients with CRKP were significantly lower than that in patients with S-Kpn (P Conclusion: Patients with BSIs-CRKP had lower leukomonocyte counts. High levels of IL-2 and IL-17A combined with immunocyte subpopulations showed relatively high diagnostic value for BSIs-S-Kpn from BSIs-CRKP. Keywords: Klebsiella pneumoniae , immunocytes, IL-2, IL-4, IL-17A Bloodstream infections (BSIs) caused by Klebsiella pneumoniae (BSIs-Kpn), especially carbapenem-resistant Kpn (CRKP), are potentially life threatening to public health. 1–3 BSIs-Kpn are responsible for 7.2% and 8.8% of community- and hospital-onset BSIs. 2 Between 2014 and 2019, the number of BSIs-CRKP in China increased substantially from 7.0% to 19.6%. 3 Previous studies have indicated that BSIs-CRKP are associated with increased morbidity and mortality. 4–6 Recent data reported that the age-standardized mortality rate of BSIs-Kpn was 3.5% of all deaths caused by 33 bacterial pathogens in 2019. 7 However, in China, the mortality rate of BSIs-CRKP has increased from 33.3% in 2012 to 42.8% in 2019. 8 Owing to the lack of appropriate antibiotic options, BSIs-CRKP have become a great challenge for clinicians. 4,5 Fortunately, the development of novel antibiotics has opened new prospects for combating BSI-CRKP. However, resistance to novel β-lactam/β-lactamase inhibitor combinations has been reported. 9 Therefore, it is important to explore the interactions between the host and the CRKP proteins. Most evidence has shown that CRKP can hide its pathogen-associated molecular patterns and induce adaptive costs to regulate immune evasion, resulting in CRKP with long-term survival in the host. 10–12 In addition, cytokines play a key role in the immune response to Kpn. 13 Herein, we conducted integrated immunology and microbiology analyses to investigate the differences in the inflammatory response among CRKP, extended-spectrum β-lactamases (ESBL) producing Kpn (ESBL-Kpn), and non-CRKP or non-ESBL-Kpn (susceptible Kpn, S-Kpn). This study was an observational analysis. The clinical diagnosis of BSIs-Kpn among adult patients was screened by positive blood culture -Abstract Truncated-
pharmacology & pharmacy,infectious diseases